Artificial Organ And Bionics Market Report 2026

Artificial Organ And Bionics Market Overview

• Artificial Organ And Bionics market size has reached to $35.86 billion in 2025 • Expected to grow to $63.1 billion in 2030 at a compound annual growth rate (CAGR) of 12.1% • Growth Driver: Rising Transplant Rates Fueling Growth In Artificial Organ And Bionics Market • Market Trend: Driving Mobility Through Innovative Prosthetic Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Organ And Bionics Market?

Artificial organs and bionics refer to any machine, or device that has been used to replace the functions of a defective or missing organ of the body and bionics is the science of constructing artificial systems that are having few characteristics of living systems. The use of artificial organs is to increase a person's life. The main products of artificial organ and bionics are artificial organs and artificial bionics. Artificial organ refers TP any machine, device that have been used to replace the functions of a missing organ or other part of the human body. The fixation types are implantable and externally-worn, cardiac bionics and brain bionics. The technologies involved mechanical bionics and electronic bionics.

What Is The Artificial Organ And Bionics Market Growth Forecast?

The artificial organ and bionics market size is expected to see rapid growth in the next few years. It will grow to $63.1 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing investments in biohybrid organ research, rising demand for intelligent bionic systems, expansion of brain-computer interface applications, growing focus on quality-of-life enhancement, technological convergence in organ replacement therapies. Major trends in the forecast period include increasing development of advanced artificial organs, rising adoption of bionic limbs and exoskeletons, growing integration of neural interface technologies, expansion of implantable life-support devices, enhanced focus on long-term organ replacement solutions.

Global Artificial Organ And Bionics Market Segmentation

1) By Product: Artificial Organs, Artificial Bionics 2) By Fixation Type: Implantable Artificial Organs and Bionics, Externally Worn Artificial Organs and Bionics, Hybrid Systems 3) By Technology: Mechanical Bionics, Electronic Bionics Subsegments: 1) By Artificial Organs: Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs 2) By Artificial Bionics: Bionic Limbs, Bionic Eyes, Exoskeletons, Neural Prosthetics

What Is The Driver Of The Artificial Organ And Bionics Market?

An increasing number of transplants is expected to propel the growth of the artificial organ and bionics market going forward. Transplant refers to the surgical procedure in a human or animal in which a body tissue or organ is transferred from a donor to a recipient or from one part of the body to another. Artificial organs are devices that have been implanted in the body to replace the damaged organ and to perform specific functioning of the natural organ which helps the patient to lead a normal life as before. For instance, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit scientific and educational organization, the US recorded 48,149 organ transplants in 2024, surpassing 48,000 and reflecting a 3.3% increase compared to 2023. Of these, 41,119 transplants were from deceased donors, while 7,030 were from living donors. Therefore, the increasing number of transplants is expected to drive the growth of the artificial organ and bionics industry.

Key Players In The Global Artificial Organ And Bionics Market

Major companies operating in the artificial organ and bionics market are Abiomed Inc., Asahi Kasei Medical Co. Ltd, Baxter, Berlin Heart GmbH, Cyberonics Inc., Ekso Bionics Holdings Inc., Getinge AB, Medtronic PLC, Bornlife Prosthetic and Orthotic Inc., Nano Retina Ltd, Edwards Lifesciences Corporation, Sonova, Cochlear Limited, Advanced Bionics AG, Ottobock SE & Co. KGaA, Second Sight Medical Products Inc., iWalk Inc., Jarvik Heart Inc., St. Jude Medical Inc., Harmonic Bionics Inc., Open Bionics, Beta Bionics Inc., Bionic Prosthetics and Orthotics, Mobius Bionics, Touch Bionics Ltd

Global Artificial Organ And Bionics Market Trends and Insights

Major companies operating in the artificial organs and bionics market are focusing on innovative technological advancement, such as microprocessor-controlled prosthetic knees to enhance mobility and promote natural, intuitive movement for lower-limb amputees. Microprocessor-controlled prosthetic knees refer to devices with sensors and embedded processors that adapt to the user’s gait in real-time. For instance, in January 2025, BionicM, a Japan-based startup and University of Tokyo spin-off specializing in robotics and prosthetics, launched its Bio Leg in the U.S. market. This powered knee, recognized as a CES 2025 Best of Innovation winner, replaces lost muscle function with robotics, offering seamless movement, improved safety, and enhanced quality of life for amputees.

What Are Latest Mergers And Acquisitions In The Artificial Organ And Bionics Market?

In November 2024, OrganOx Ltd, a UK-based organ technology company focused on normothermic perfusion systems for donor organs, partnered with eGenesis to clinically co-develop an organ support therapy that integrates OrganOx’s perfusion platform with genetically engineered porcine livers for the treatment of acute liver failure. Through this collaboration, OrganOx aims to advance its presence in the artificial organ and bionics market by enabling a new biologically engineered liver support option that can improve patient outcomes and expand access to organ replacement solutions. eGenesis is a US-based biotechnology company specializing in genome-engineered organs and cells for transplantation.

Regional Outlook

North America was the largest region in the artificial organ and bionics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global artificial organ and bionics market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Artificial Organ And Bionics Market?

The artificial organs and bionics market consists of sales of artificial hearts, total artificial hearts (TAH), artificial kidneys, artificial livers, ear bionics, vision bionics, orthopedic bionics, and heart bionics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.